PN

Piyush Naranbhai Paghadal

Active Director Director DIN 11493717
DIN 11493717 First appointment Jan 2026 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value •••• Premium profile

About Piyush Naranbhai Paghadal

Data last updated:

Piyush Naranbhai Paghadal is a Director at Jark Pharma Private Limited (since 2026). The company operates in Healthcare. Jark Pharma Private Limited reported revenue of ₹14.8 Lakh (FY 2025).

DIN 11493717
Primary Designation Director
Industry Healthcare
First Appointment 20 Jan 2026
Largest company Jark Pharma Private Limited · ₹14.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jark Pharma Private Limited U24231GJ2001PTC039355
Director20 Jan 2026₹14.8 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Jark Pharma Private Limited
Premium access

Shareholding and investment profile for Piyush Naranbhai Paghadal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Piyush Naranbhai Paghadal

Piyush Naranbhai Paghadal currently holds 1 directorship: Jark Pharma Private Limited (Director, since 20 Jan 2026, revenue ₹14.8 Lakh (FY 2025)).

Piyush Naranbhai Paghadal was first appointed on 20 Jan 2026 as Director at Jark Pharma Private Limited.

The current boards of Piyush Naranbhai Paghadal's companies include Gandubhai Tapubhai Movaliya (Jark Pharma Private Limited), Kailesh Gandubhai Movaliya (Jark Pharma Private Limited), Maganbhai Tapubhai Movaliya (Jark Pharma Private Limited), Nayanbhai Maganbhai Movalia (Jark Pharma Private Limited), Rajesh Gandubhai Movaliya (Jark Pharma Private Limited), Satish Maganbhai Movaliya (Jark Pharma Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available